Literature DB >> 26405470

A case report of vasa previa incidentally discovered.

Salahiddine Saghir1, Jaouad Kouach2, Aomar Agadr1.   

Abstract

Vasa previa is a rare but clinically important obstetrical complication that can be associated with a low-lying placenta or placenta previa. We aim to present one case of vasa previa diagnosed during the placenta examination after the caesarean indicated for triple uterus scar. A 26-year-old female was referred to our hospital at 30 weeks of gestation to provide a scheduled caesarean. Trans-abdominal ultrasound was performed; the placenta was positioned in the posterior side of the fundus. Fetal growth was found to be appropriate for gestational age. A healthy male infant weighing was successfully delivered via cesarean section at 38 weeks of gestation. This operation helped to prevent complications due to acute fetal bleeding. The identification and exclusion of vasa previa using trans-vaginal ultrasound are essential to ensure appropriate and timely treatment.

Entities:  

Keywords:  Benckiser′s haemorrhage; Vasa previa; fetal bleeding

Mesh:

Year:  2015        PMID: 26405470      PMCID: PMC4564431          DOI: 10.11604/pamj.2015.21.34.6697

Source DB:  PubMed          Journal:  Pan Afr Med J


Introduction

Vasa previa is a rare but clinically important obstetrical complication in which fetal blood vessels are positioned between the presenting part and cervix, and it can be associated with a low-lying placenta or placenta previa. The estimated incidence of vasa previa is approximately 1 in 2500 deliveries, but it is much higher (1 in 700) among patients who conceive through assisted reproductive technologies. The importance and clinical impact of an antenatal diagnosis of vasa previa is very significant because of the likelihood of adverse fetal outcomes [1]. Because the vessels are attached to the chorion, rupture of fetal membranes can result in fetal bleeding and death within minutes. When the condition is not diagnosed antenatally, the perinatal mortality rate is reported to be approximately 44%, whereas 97% of fetuses survive when an antenatal diagnosis is made, indicating significantly different outcomes [2, 3]. Furthermore, a low-lying placenta is reportedly a risk factor for vasa previa because it occurs in 5% of patients [4]. Accurate diagnosis of vasa previa is therefore crucial. Here, we describe a case of vasa previa incidentally discovered at the end of surgery.

Patient and observation

A 26-year-old female (gravida 4, para 3) was referred to our hospital at 30 weeks of gestation to provide a scheduled caesarean. Trans-abdominal ultrasound was performed; the placenta was positioned in the posterior side of the fundus. Fetal growth was found to be appropriate for gestational age. The patient was admitted at 38 weeks of gestation to the surgery room according to the guidelines for the management of the uterine multiple scars. A healthy male infant weighing was successfully delivered via cesarean section, the Apgar score was 9/10/10 with no blood loss during delivery. The evaluation of the placenta confirmed the diagnosis of vasa previa (Figure 1). The postoperative course of the patient and the infant was uncomplicated and they were discharged 3 days after delivery in a healthy condition.
Figure 1

Placenta examination showing vasa previa

Placenta examination showing vasa previa

Discussion

Previously, vasa previa was usually detected by palpation of the fetal vessels within the membranes during labor or on the basis of acute-onset vaginal bleeding and subsequent fetal bradycardia and/or death after membrane rupture. As discussed above, the importance of an accurate diagnosis of vasa previa is significant; if not diagnosed antenatally, the neonatal survival rate is only 44% with a neonatal transfusion rate of 58.5% [2]. A universal screening method for the detection of vasa previa has not yet been established [5] although high-risk factors have been identified [6]. Baulies et al. reported that the incidence of vasa previa was 0.07%, and multivariate analysis revealed the following associated factors in their study. In vitro fertilization (IVF) pregnancies, Therefore, if patients present with any of these risk factors, a concerted effort to detect vasa previa using ultrasound screening in the second trimester is necessary [7]. Screening for high-risk patients (such as those with IVF pregnancies, a velamentous cord, a low-lying placenta, low cord insertions in the uterus, or a low-lying bilobate placenta) has shown some success [1, 8, 9]. The primary methods of diagnosis are trans-vaginal ultrasonography and real-time color Doppler ultrasonography, and most cases are diagnosed antenatally. Unfortunately, in our case detailed ultrasonography in the second trimester for the screening of vasa previa and to detect the cord insertion was not performed; therefore, it was difficult to make diagnosis of vasa previa.

Conclusion

We presented a case of vasa previa diagnosed postoperatively during caesarean scheduled for uterine multiple scars, which helped to prevent complications due to acute fetal bleeding. The identification and exclusion of vasa previa using trans-vaginal ultrasound are essential to ensure appropriate and timely treatment.
  9 in total

1.  Analysis of the ultrasonographic findings predictive of vasa previa.

Authors:  Junichi Hasegawa; Antonio Farina; Masamitsu Nakamura; Ryu Matsuoka; Kiyotake Ichizuka; Akihiko Sekizawa; Takashi Okai
Journal:  Prenat Diagn       Date:  2010-12       Impact factor: 3.050

2.  Prenatal ultrasound diagnosis of vasa praevia and analysis of risk factors.

Authors:  S Baulies; N Maiz; A Muñoz; M Torrents; M Echevarría; B Serra
Journal:  Prenat Diagn       Date:  2007-07       Impact factor: 3.050

3.  The association between vasa previa, multiple gestations, and assisted reproductive technology.

Authors:  Manisha Gandhi; Jane Cleary-Goldman; Lauren Ferrara; Doina Ciorica; Daniel Saltzman; Andrei Rebarber
Journal:  Am J Perinatol       Date:  2008-10-10       Impact factor: 1.862

Review 4.  Vasa previa: an avoidable obstetric tragedy.

Authors:  K O Oyelese; M Turner; C Lees; S Campbell
Journal:  Obstet Gynecol Surv       Date:  1999-02       Impact factor: 2.347

Review 5.  Poor perinatal outcome associated with vasa previa: is it preventable? A report of three cases and review of the literature.

Authors:  T Y Fung; T K Lau
Journal:  Ultrasound Obstet Gynecol       Date:  1998-12       Impact factor: 7.299

6.  Prenatal diagnosis and management of vasa previa: a 6-year review.

Authors:  Eriko Kanda; Yoshio Matsuda; Masato Kamitomo; Takatsugu Maeda; Keiko Mihara; Masayuki Hatae
Journal:  J Obstet Gynaecol Res       Date:  2011-05-22       Impact factor: 1.730

7.  The cost-effectiveness of targeted or universal screening for vasa praevia at 18-20 weeks of gestation in Ontario.

Authors:  L E Cipriano; W H Barth; G S Zaric
Journal:  BJOG       Date:  2010-06-18       Impact factor: 6.531

Review 8.  Guidelines for the management of vasa previa.

Authors:  Robert Gagnon
Journal:  J Obstet Gynaecol Can       Date:  2009-08

9.  Vasa previa: the impact of prenatal diagnosis on outcomes.

Authors:  Yinka Oyelese; Val Catanzarite; Federico Prefumo; Susan Lashley; Morey Schachter; Yosi Tovbin; Victoria Goldstein; John C Smulian
Journal:  Obstet Gynecol       Date:  2004-05       Impact factor: 7.661

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.